(Q54695730)

2 June 2018

title

Oncogenic and tumor suppressive roles of polo-like kinases in human hepatocellular carcinoma. (English)

1 reference

2 June 2018

author name string

Rossella Pellegrino

1

1 reference

2 June 2018

Diego F Calvisi

2

1 reference

2 June 2018

Sara Ladu

3

1 reference

2 June 2018

Volker Ehemann

4

1 reference

2 June 2018

Tommaso Staniscia

5

1 reference

2 June 2018

Matthias Evert

6

1 reference

2 June 2018

Frank Dombrowski

7

1 reference

2 June 2018

Peter Schirmacher

8

1 reference

2 June 2018

Thomas Longerich

9

1 reference

2 June 2018

language of work or name

English

0 references

publication date

1 March 2010

1 reference

2 June 2018

published in

Hepatology

1 reference

2 June 2018

volume

51

1 reference

2 June 2018

issue

3

1 reference

2 June 2018

page(s)

857-868

1 reference

2 June 2018

Expression and phosphorylation of fibroblast-growth-factor-inducible kinase (Fnk) during cell-cycle progression

cites work

1 reference

p73-mediated transcriptional activity is negatively regulated by polo-like kinase 1.

21 January 2018

1 reference

Polo-like kinases and the orchestration of cell division

21 January 2018

1 reference

7 January 2021

Structure and function of Polo-like kinases

1 reference

7 January 2021

Polo-like kinases and oncogenesis

1 reference

7 January 2021

Differential regulation of polo-like kinase 1, 2, 3, and 4 gene expression in mammalian cells and tissues

1 reference

7 January 2021

Polo-like kinase-2 is required for centriole duplication in mammalian cells

1 reference

7 January 2021

Mammalian Polo-like kinase 3 (Plk3) is a multifunctional protein involved in stress response pathways

1 reference

7 January 2021

Polo-like kinase 3 is required for entry into S phase

1 reference

7 January 2021

Cell cycle arrest and apoptosis induced by human Polo-like kinase 3 is mediated through perturbation of microtubule integrity

1 reference

7 January 2021

Polo-like kinase 3 is Golgi localized and involved in regulating Golgi fragmentation during the cell cycle

1 reference

7 January 2021

Late mitotic failure in mice lacking Sak, a polo-like kinase.

1 reference

7 January 2021

Sak/Plk4 and mitotic fidelity

1 reference

7 January 2021

The Polo kinase Plk4 functions in centriole duplication

1 reference

7 January 2021

Malignant transformation of mammalian cells initiated by constitutive expression of the polo-like kinase

1 reference

7 January 2021

Aberrant Polo-like kinase 1-Cdc25A pathway in metastatic hepatocellular carcinoma

1 reference

7 January 2021

The Cdc14B-Cdh1-Plk1 axis controls the G2 DNA-damage-response checkpoint

1 reference

7 January 2021

Transcriptional silencing of Polo-like kinase 2 (SNK/PLK2) is a frequent event in B-cell malignancies.

1 reference

7 January 2021

Polo-like kinase 3 functions as a tumor suppressor and is a negative regulator of hypoxia-inducible factor-1 alpha under hypoxic conditions

1 reference

7 January 2021

Plk4 haploinsufficiency causes mitotic infidelity and carcinogenesis.

1 reference

7 January 2021

Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling.

1 reference

7 January 2021

Flow cytometric DNA analysis and chromosomal aberrations in malignant glioblastomas.

1 reference

7 January 2021

Simplified mammalian DNA isolation procedure

1 reference

7 January 2021

MethPrimer: designing primers for methylation PCRs

1 reference

7 January 2021

Disruption of beta-catenin pathway or genomic instability define two distinct categories of liver cancer in transgenic mice

1 reference

7 January 2021

Overexpression of PLK1 is associated with poor survival by inhibiting apoptosis via enhancement of survivin level in esophageal squamous cell carcinoma

1 reference

7 January 2021

Polo-like kinase 1 (Plk1) inhibits p53 function by physical interaction and phosphorylation

1 reference

7 January 2021

Inhibitory role of Plk1 in the regulation of p73-dependent apoptosis through physical interaction and phosphorylation

1 reference

7 January 2021

The mouse Forkhead Box m1 transcription factor is essential for hepatoblast mitosis and development of intrahepatic bile ducts and vessels during liver morphogenesis

1 reference

7 January 2021

Forkhead box M1B is a determinant of rat susceptibility to hepatocarcinogenesis and sustains ERK activity in human HCC

1 reference

7 January 2021

A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene

1 reference

7 January 2021

Ubiquitous activation of Ras and Jak/Stat pathways in human HCC.

1 reference

7 January 2021

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

1 reference

7 January 2021

Molecular targeted therapies in hepatocellular carcinoma

1 reference

7 January 2021

Plk1-dependent phosphorylation of FoxM1 regulates a transcriptional programme required for mitotic progression

1 reference

7 January 2021

Multiple genetic alterations, 4q28, a new suppressor region, and potential gender differences in human hepatocellular carcinoma

1 reference

7 January 2021

Molecular pathogenesis of human hepatocellular carcinoma

1 reference

7 January 2021

Hepatocellular carcinoma pathogenesis: from genes to environment

1 reference

7 January 2021

Downregulation of human polo-like kinase activity by antisense oligonucleotides induces growth inhibition in cancer cells

1 reference

7 January 2021

Polo-like kinase (Plk)1 depletion induces apoptosis in cancer cells

1 reference

7 January 2021

A panel of isogenic human cancer cells suggests a therapeutic approach for cancers with inactivated p53

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.23467

1 reference

2 June 2018

1 reference

2 June 2018